279 related articles for article (PubMed ID: 31421368)
1. Benefits of Surgery After Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients With Peritoneal Metastasis: A Meta-Analysis.
Gong Y; Wang P; Zhu Z; Zhang J; Huang J; Wang T; Chen J; Xu H
J Surg Res; 2020 Jan; 245():234-243. PubMed ID: 31421368
[TBL] [Abstract][Full Text] [Related]
2. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis.
Zhang X; Huang H; Yang D; Wang P; Huang X; Hu Z; Zhang Y; Yan R; Zhu Z; Cai Q
Technol Cancer Res Treat; 2021; 20():15330338211036310. PubMed ID: 34328799
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of conversion surgery after neoadjuvant intraperitoneal-systemic chemotherapy in treating peritoneal metastasis of gastric cancer.
Li Y; Lin H; Huang K; Zhao J
J BUON; 2021; 26(1):211-217. PubMed ID: 33721454
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance and practice points of conversion therapy for gastric cancer with peritoneal metastasis].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1094-1098. PubMed ID: 29130218
[TBL] [Abstract][Full Text] [Related]
7. The use of intraperitoneal chemotherapy for gastric malignancies.
Macrì A; Morabito F
Expert Rev Anticancer Ther; 2019 Oct; 19(10):879-888. PubMed ID: 31544548
[No Abstract] [Full Text] [Related]
8. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant treatment of gastric cancer with peritoneal dissemination.
Yonemura Y; Bandou E; Sawa T; Yoshimitsu Y; Endou Y; Sasaki T; Sugarbaker PH
Eur J Surg Oncol; 2006 Aug; 32(6):661-5. PubMed ID: 16621433
[TBL] [Abstract][Full Text] [Related]
10. A phase III trial of neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis.
Lu S; Yang ZY; Yan C; Liu WT; Ni ZT; Yao XX; Hua ZC; Feng RH; Zheng YN; Wang ZQ; Sah BK; Chen MM; Zhu ZL; He CY; Li C; Yan M; Zhu ZG
Future Oncol; 2022 Mar; 18(10):1175-1183. PubMed ID: 35114800
[TBL] [Abstract][Full Text] [Related]
11. Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer.
Yonemura Y; Ishibashi H; Hirano M; Mizumoto A; Takeshita K; Noguchi K; Takao N; Ichinose M; Liu Y; Li Y
Ann Surg Oncol; 2017 Feb; 24(2):478-485. PubMed ID: 27506661
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
13. A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial.
Takahashi N; Kanda M; Yoshikawa T; Takiguchi N; Fujitani K; Miyamoto K; Ito Y; Takayama O; Imano M; Mitsumori N; Sakamoto J; Morita S; Kodera Y
Gastric Cancer; 2018 Nov; 21(6):1014-1023. PubMed ID: 29536296
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study.
Yang ZY; Yuan F; Lu S; Xu W; Wu JW; Xi WQ; Shi M; Wang ZQ; Ni ZT; He CY; Yao XX; Zheng YN; Zhu ZL; Liu WT; Zhang J; Zhang H; Li C; Yan C; Yan M; Zhu ZG
Front Oncol; 2022; 12():905922. PubMed ID: 35795055
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
[TBL] [Abstract][Full Text] [Related]
16. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
17. [Laparoscopic diagnosis of postoperative recurrence of peritoneal metastasis in gastric cancer patients and the clinical efficacy of bidirectional intraperitoneal and systemic chemotherapy].
Yan C; Yang ZY; Shi M; Xu W; Ni ZT; Hua ZC; Liu WT; Zhu ZL; Bi RD; Zheng YN; Feng RH; Yao XX; Chen MM; Li C; Zhang J; Yan M; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):492-498. PubMed ID: 32842430
[No Abstract] [Full Text] [Related]
18. Systemic Chemotherapy using FLOT - Regimen Combined with Cytoreductive Surgery plus HIPEC for Treatment of Peritoneal Metastasized Gastric Cancer.
Müller H; Hotopp T; Tofeili A; Wutke K
Hepatogastroenterology; 2014 May; 61(131):703-6. PubMed ID: 26176060
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Jan; 105(1):38-42. PubMed ID: 21882194
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of paclitaxel combined with S-1 in the prevention and treatment of gastric cancer with peritoneal metastasis].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):979-82. PubMed ID: 26499139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
